Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study.

Int J Endocrinol · 2019 · PMC6381585 · PMID 30881452

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

During the first year after treatment discontinuation, spine BMD remained unchanged while hip BMD slightly decreased, but the differences versus BL remained highly significant [ 7 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.